Written by Behind the scenes, as tumors progress and gain resistance to treatment, a protein called YB-1 quietly gives directions. Now, researchers at Oregon Health & Science University have developed a first-of-its-kind drug that inhibits YB-1, effectively silencing those orders.
Medical Xpress – latest medical and health news stories